Always good to see a company with plenty of cash in the bank and no debt.
I know I mentioned previously, yet both US customers signed up in December, and total revenue from US for that period (December) is$623k. Orders fulfilled for January / February which suggests continuous good revenue stream from the US alone as that is roughly $1.9m per quarter just there.
Also note
" EMEA contributed A$2.96m to revenue in the half, up from A$0.09m pcp, and A$0.77m for FY20. New supply agreements have been signed during December and January and will further contribute to revenue"
This suggests additional revenue over coming quarters will more than compensate for any dip in covid testing.
- Forums
- ASX - By Stock
- GSS
- Ann: Half Yearly Report and Accounts
GSS
genetic signatures limited
Add to My Watchlist
2.67%
!
36.5¢

Ann: Half Yearly Report and Accounts, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $82.90M |
Open | High | Low | Value | Volume |
36.5¢ | 36.5¢ | 36.5¢ | $160 | 438 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 19601 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 32411 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14601 | 0.365 |
2 | 9513 | 0.360 |
3 | 30509 | 0.350 |
1 | 1683 | 0.300 |
1 | 25000 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 32411 | 1 |
0.380 | 3086 | 1 |
0.390 | 20000 | 1 |
0.395 | 5000 | 1 |
0.400 | 111918 | 2 |
Last trade - 13.38pm 04/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online